NCT02298452

Brief Summary

The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and functions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
253

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

May 3, 2016

Status Verified

May 1, 2016

Enrollment Period

2.3 years

First QC Date

November 17, 2014

Last Update Submit

May 2, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference of speech intelligibility between devices based on Quest platform and Venture platform for different hearing aid styles

    For the objective measurements in laboratory situation, both a standard German speech sentence test in noise (SRT in dB) and a standard German monosyllable word test in quiet (speech discrimination in percent) are used to compare the speech intelligibility for both platforms. The results of the Venture platform of both tests should be at least the same or better than with the Quest platform.

    3 years

Secondary Outcomes (3)

  • Subjective ratings of speech intelligibility during home trials

    3 years

  • Subjective ratings of sound quality during home trials

    3 years

  • Subjective ratings of usability during home trials

    3 years

Study Arms (1)

Hearing aid

OTHER

172 subjects with a mild hearing loss. 140 subjects with a moderate hearing loss. 70 subjects with a severe/ profound hearing loss.

Device: Hearing aid.

Interventions

The hearing aid will be fitted to the individual hearing loss of the subject.

Hearing aid

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all kinds of hearing loss (sensorineural, conductive, combined)
  • all kinds of hearing loss (flat, sloping) which are in the fitting range of the hearing aids
  • mother tongue (swiss) german

You may not qualify if:

  • Subjects
  • with a reduced mobility unable to attend weekly study appointments
  • without access to a number of different hearing situations
  • with strongly reduced ability to describe auditory impressions and the usage of the hearing aids
  • which are uncooperative so that it is not possible to record a valid pure tone audiogram
  • with a strongly reduced dexterity
  • with psychological problems
  • central hearing disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Phonak AG

Stäfa, Canton of Zurich, 8712, Switzerland

Location

MeSH Terms

Conditions

Hearing Loss

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Study Officials

  • Simone Ebbing, B. Sc.

    Phonak AG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2014

First Posted

November 24, 2014

Study Start

May 1, 2013

Primary Completion

August 1, 2015

Study Completion

September 1, 2015

Last Updated

May 3, 2016

Record last verified: 2016-05

Locations